In short
This article discusses a clinical trial investigating the use of Cefotaxime Sodium, along with other antibiotics, in children with malignant brain tumors. The study aims to understand how these antibiotics behave in the body, particularly in the cerebrospinal fluid, to improve treatment for young patients with brain cancer.
At a glance
- Study Type
- Phase I clinical trial in patients
- Main Objective
- Measure antibiotic concentrations in CSF and plasma of children with malignant brain tumors
- Age Range
- 0-18 years
- Key Inclusion Criteria
- CNS tumor with leptomeningeal dissemination, ongoing antibiotic treatment, intrathecal chemotherapy
- Primary Endpoints
- AUC0-τ, AUC0-24, drug concentration at various time points, distribution from plasma to CSF
- Secondary Endpoints
- AUC0-24/MIC ratio, %T>MIC, Cmax/MIC ratio, target attainment for relevant pathogens
- Drug Information
- Cefotaxime Sodium, administered intravenously, pharmaceutical form: solution for injection/infusion
What is Cefotaxime Sodium?
Cefotaxime Sodium is an antibiotic medication used to treat various bacterial infections. It belongs to a class of antibiotics called cephalosporins, which are effective against a wide range of bacteria. Cefotaxime Sodium is also known by its brand name Cefotaxim-MIP 1 g, which is available as a powder for making a solution for injection or infusion.
Medical Uses
Cefotaxime Sodium is primarily used to treat bacterial infections. While the specific details of its use are not provided in the given information, cephalosporins like Cefotaxime are generally used to treat a variety of infections, including:
- Respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
- Bone and joint infections
- Meningitis (infection of the brain and spinal cord membranes)
In the context of the clinical trial mentioned, Cefotaxime Sodium is being studied for its potential use in children with malignant brain tumors who may have or be at risk of leptomeningeal dissemination (spread of cancer cells to the membranes covering the brain and spinal cord).
How is Cefotaxime Sodium Administered?
Cefotaxime Sodium is administered as a solution for injection or infusion. This means it can be given in two ways:
- Intravenous infusion: The medication is slowly dripped into a vein over a period of time.
- Injection: The medication is directly injected into a vein or muscle.
The method of administration will depend on the specific condition being treated and the patient's overall health status. Always follow your healthcare provider's instructions on how to take this medication.
Current Clinical Trial
A clinical trial is currently being conducted to study the use of Cefotaxime Sodium and other antibiotics in children with malignant brain tumors. This trial is classified as a Phase I clinical trial, which means it's one of the earliest stages of testing a new treatment in humans.
The main objective of this trial is to measure the concentrations of different antibiotics, including Cefotaxime Sodium, in the cerebrospinal fluid (CSF) and plasma after intravenous or oral administration in children with malignant brain tumors. CSF is the fluid that surrounds the brain and spinal cord.
Understanding Pharmacokinetics
The study focuses on the pharmacokinetics of antibiotics like Cefotaxime Sodium. Pharmacokinetics refers to how a drug moves through the body, including how it's absorbed, distributed, metabolized, and excreted. In this study, researchers are particularly interested in:
- How much of the antibiotic reaches the cerebrospinal fluid
- How long the antibiotic stays in the body
- How the concentration of the antibiotic changes over time
This information is crucial for determining the most effective dosing strategies for these antibiotics in children with brain tumors.
Eligibility Criteria for the Study
The study has specific criteria for who can participate. These include:
Inclusion Criteria:
- Children aged 0 to 18 years (at the time of initial diagnosis)
- Diagnosed with a brain tumor that has spread to the leptomeninges (the membranes covering the brain and spinal cord) or is at risk of doing so
- Currently receiving antibiotic treatment (either intravenous or oral) for medical reasons
- Undergoing intrathecal chemotherapy (chemotherapy delivered directly into the CSF) via an Ommaya reservoir (a special device implanted under the scalp)
- Life expectancy of at least 8 weeks
Exclusion Criteria:
- Not requiring antibiotic treatment or intrathecal therapy
- Having conditions that make it unsafe to access the Ommaya reservoir or administer intrathecal chemotherapy
- Pregnancy or breastfeeding
These criteria ensure that the study includes patients who can potentially benefit from the research while minimizing risks.
Study Endpoints
The study has several endpoints, which are the main results that the researchers will measure to determine if the treatment is effective. For Cefotaxime Sodium and other antibiotics in the study, these include:
- How much of the antibiotic is present in the body over time (measured as the Area Under the Curve or AUC)
- The concentration of the antibiotic at different time points during and after treatment
- How well the antibiotic moves from the blood into the cerebrospinal fluid
- How the concentration of the antibiotic in the CSF compares to the minimum amount needed to kill bacteria (known as the Minimum Inhibitory Concentration or MIC)
- How long the antibiotic concentration in the CSF stays above the MIC
These measurements will help doctors understand how to best use Cefotaxime Sodium and other antibiotics in children with brain tumors, potentially improving treatment outcomes.